kff 2025 employer health benefits survey glp-1 coverage Benefit kff employer health benefits survey

It is provided for general informational and educational purposes and does not constitute medical advice, clinical guidance, or a substitute for the independent professional judgment of a licensed physician or other qualified healthcare provider

Reasons for discontinuation of GLP1 receptor agonists: Data from a real-world cross-sectional survey of physicians and their patients with type 2 diabetes

Cefalu et al

You really dont know when in somebodys lifetime theyre going to have a clinically significant cancer, McGuire said

The gastroparesis or stomach paralysis lawsuits involve patients who experienced severe gastrointestinal injuries such as stomach paralysis (gastroparesis), bowel obstruction, and related complications